Valuation: Xcelerate Inc.

Market Cap 94.93L 83.49L 78.95L 71.61L 1.34Cr 91Cr 1.35Cr 9.45Cr 3.65Cr 46Cr 3.56Cr 3.49Cr 149.42Cr P/E 2022
-16x
P/E 2023 -5.46x
Enterprise Value 1.07Cr 94.08L 88.97L 80.69L 1.52Cr 102.69Cr 1.52Cr 11Cr 4.11Cr 52Cr 4.02Cr 3.93Cr 168.38Cr EV / Sales 2022
-
EV / Sales 2023 1,50,04,302x
Free-Float
58.58%
Yield 2022 *
-
Yield 2023 -
1 day+4.70%
1 week+16.43%
Current month+90.52%
1 month+90.52%
3 months+100.96%
6 months+153.64%
Current year+138.86%
1 week 0.02
Extreme 0.0176
0.02
1 month 0.01
Extreme 0.009
0.03
Current year 0.01
Extreme 0.0067
0.03
1 year 0.01
Extreme 0.0061
0.03
3 years 0.01
Extreme 0.0061
0.06
5 years 0.01
Extreme 0.0061
0.14
10 years 0
Extreme 0.0004
0.17
Manager TitleAgeSince
Chief Executive Officer - 01/05/2020
Chief Tech/Sci/R&D Officer - 04/09/2020
Director TitleAgeSince
Director/Board Member - 23/07/2020
Chairman - -
Director/Board Member - 04/08/2020
Change 5-day change 1-year change 3-year change Capi.($)
+4.70%+16.43%+34.84%-54.53% 86.89L
-1.44%+0.29%+16.25%+25.45% 11TCr
-0.69%+1.56%+2.77%+72.59% 9.43TCr
+1.27%+0.50%-0.43%+58.97% 2.96TCr
+0.55%-2.96%+25.83%+92.64% 2.61TCr
0.00%-3.04%-14.49%-5.67% 2.08TCr
-0.69%-1.16%+28.20%+283.03% 2.09TCr
+0.21%-1.71%-11.42%+50.24% 1.57TCr
+1.71%+4.63%-7.30%-1.82% 1.2TCr
-0.22%-2.34%+36.36%+84.91% 1.14TCr
Average +0.69%-0.31%+11.06%+60.58% 3.45TCr
Weighted average by Cap. -0.11%+0.29%+9.31%+62.19%

Financials

2022 2023
Net sales - 1.12 0.99 0.93 0.85 1.59 107.71 1.6 11.17 4.32 54.96 4.21 4.12 176.62
Net income -8L -7L -7L -6L -11.97L -8.11Cr -12.03L -84.1L -32.48L -4.14Cr -31.71L -31.02L -13Cr -27.51L -24.19L -22.88L -20.75L -38.97L -26Cr -39.19L -2.74Cr -1.06Cr -13Cr -1.03Cr -1.01Cr -43Cr
Net Debt 1L 99.61T 94.19T 85.43T 2L 1.09Cr 2L 11.28L 4L 55.47L 4L 4L 1.78Cr 12.05L 10.6L 10.02L 9L 17.07L 12Cr 17.17L 1.2Cr 46.33L 5.9Cr 45.23L 44.25L 19Cr
Logo Xcelerate Inc.
Xcelerate, Inc. is a healthcare services and products company. The Company is engaged in three separate but related businesses within the medical, health and wellness sectors. The Company is focused on the development of medical technology and virtual health services to help patients in developing countries meet their medical needs by extending the reach of physicians through the technology; the formulation, packaging and marketing of consumer health and beauty, clinically tested skin and hair care products, and owning and licensing the rights to various forms of medical equipment.
Employees
12
Date Price Change Volume
29/26/29 $0.0209 +4.70% 33,000
25/26/25 $0.0200 -9.09% 2,37,080
24/26/24 $0.0220 -9.09% 1,90,000
23/26/23 $0.0242 +10.50% 6,500
22/26/22 $0.0219 +22.01% 1,04,500
  1. Stock Market
  2. Stocks
  3. XCRT Stock